BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 9834099)

  • 1. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
    J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
    Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
    J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
    Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
    J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.
    Ponath PD; Qin S; Ringler DJ; Clark-Lewis I; Wang J; Kassam N; Smith H; Shi X; Gonzalo JA; Newman W; Gutierrez-Ramos JC; Mackay CR
    J Clin Invest; 1996 Feb; 97(3):604-12. PubMed ID: 8609214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
    Jinquan T; Quan S; Feili G; Larsen CG; Thestrup-Pedersen K
    J Immunol; 1999 Apr; 162(7):4285-92. PubMed ID: 10201960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
    Ponath PD; Qin S; Post TW; Wang J; Wu L; Gerard NP; Newman W; Gerard C; Mackay CR
    J Exp Med; 1996 Jun; 183(6):2437-48. PubMed ID: 8676064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
    Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
    J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration.
    Borchers MT; Ansay T; DeSalle R; Daugherty BL; Shen H; Metzger M; Lee NA; Lee JJ
    J Leukoc Biol; 2002 Jun; 71(6):1033-41. PubMed ID: 12050190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a mouse eosinophil receptor for the CC chemokine eotaxin.
    Gao JL; Sen AI; Kitaura M; Yoshie O; Rothenberg ME; Murphy PM; Luster AD
    Biochem Biophys Res Commun; 1996 Jun; 223(3):679-84. PubMed ID: 8687456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
    Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
    J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.
    Shinkai A; Yoshisue H; Koike M; Shoji E; Nakagawa S; Saito A; Takeda T; Imabeppu S; Kato Y; Hanai N; Anazawa H; Kuga T; Nishi T
    J Immunol; 1999 Aug; 163(3):1602-10. PubMed ID: 10415065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
    White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
    J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
    Duchesnes CE; Murphy PM; Williams TJ; Pease JE
    Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
    Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
    J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human eotaxin induces alpha 4 and beta 2 integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4.
    Sanz MJ; Ponath PD; Mackay CR; Newman W; Miyasaka M; Tamatani T; Flanagan BF; Lobb RR; Williams TJ; Nourshargh S; Jose PJ
    J Immunol; 1998 Apr; 160(7):3569-76. PubMed ID: 9531320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3.
    Kitaura M; Nakajima T; Imai T; Harada S; Combadiere C; Tiffany HL; Murphy PM; Yoshie O
    J Biol Chem; 1996 Mar; 271(13):7725-30. PubMed ID: 8631813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of novel antagonists of the CCR3 receptor.
    Warrior U; McKeegan EM; Rottinghaus SM; Garcia L; Traphagen L; Grayson G; Komater V; McNally T; Helfrich R; Harris RR; Bell RL; Burns DJ
    J Biomol Screen; 2003 Jun; 8(3):324-31. PubMed ID: 12857386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.